Search

Your search keyword '"Mir-Viladrich, Isabel"' showing total 27 results
Start Over Author "Mir-Viladrich, Isabel"
27 results on '"Mir-Viladrich, Isabel"'

3. Early detection of lung cancer by metabolomic analysis applied to serum samples before clinical diagnosis in high-risk patients.

Author

Gotera, Carolina, primary, Pereira Vega, Antonio, additional, García Barrera, Tamara, additional, Marín Trigo, José María, additional, Casanova Macario, Ciro, additional, García-Cosío Piqueras, Borja, additional, Mir Viladrich, Isabel, additional, Solanes García, Ingrid, additional, Gómez Ariza, José Luis, additional, López-Campos Bodineau, José Luis, additional, Seijo Maceiras, Luis, additional, Feu Collado, Nuria, additional, Cabrera López, Carlos, additional, Amado Diago, Carlos, additional, Romero Plaza, Amparo, additional, Padrón Fraysse, Luis Alejandro, additional, Callejón Leblic, Belen, additional, Márquez Martín, Eduardo, additional, Marín Royo, Margarita, additional, Llunell Casanovas, Antonia, additional, Balcells Vilarnau, Eva, additional, Martínez González, Cristina, additional, Galdíz Iturri, Juan Bautista, additional, Lacárcel Bautista, Celia, additional, De Torres Tajes, Juan Pablo, additional, Díaz Olivarez, Isabel, additional, and Peces-Barba Romero, Germán, additional

Published
2023
Full Text
View/download PDF

7. [Translated article] Tuberculosis contacts tracing in Spain: Cost analysis

Author

Gullón-Blanco, José Antonio, primary, Rodrigo-Sanz, Teresa, additional, Tabernero-Huguet, Eva, additional, Sabría-Mestres, Josefina, additional, Anibarro, Luis, additional, Villanueva-Montes, Manuel-Ángel, additional, Mir-Viladrich, Isabel, additional, Álvarez-Mavarez, Juan-Diego, additional, García-García, José-María, additional, Navascues, Fernando Álvarez, additional, Somoza-González, María, additional, Anchorena, Christian, additional, Domínguez-Castellano, Ángel, additional, Penas-Truque, Antón, additional, Dorronsoro-Quintana, Silvia, additional, Medina-Gallardo, Juan-Francisco, additional, Altube-Urrengoetxea, Lander, additional, Otero-Santiago, María, additional, Rodríguez-García, Concepción, additional, and Rodríguez-López, Juan, additional

Published
2022
Full Text
View/download PDF

9. WITHDRAWN: Tuberculosis contacts tracing in Spain: Cost analysis

Author

Gullón-Blanco, José Antonio, primary, Rodrigo-Sanz, Teresa, additional, Tabernero-Huguet, Eva, additional, Sabría-Mestres, Josefina, additional, Anibarro, Luis, additional, Villanueva-Montes, Manuel-Ángel, additional, Mir-Viladrich, Isabel, additional, Álvarez-Mavarez, Juan-Diego, additional, García-García, José-María, additional, Navascues, Fernando Álvarez, additional, Somoza-González, María, additional, Anchorena, Christian, additional, Domínguez-Castellano, Ángel, additional, Penas-Truque, Antón, additional, Dorronsoro-Quintana, Silvia, additional, Medina-Gallardo, Juan-Francisco, additional, Altube-Urrengoetxea, Lander, additional, Otero-Santiago, María, additional, Rodríguez-García, Concepción, additional, and Rodríguez-López, Juan, additional

Published
2021
Full Text
View/download PDF

10. Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD

Author

Casanova, Ciro, Marin, Jose M., Martinez-Gonzalez, Cristina, de Lucas-Ramos, Pilar, Mir-Viladrich, Isabel, Cosio, Borja, Peces-Barba, German, Solanes-García, Ingrid, Agüero, Ramón, Feu-Collado, Nuria, Calle-Rubio, Miryam, Alfageme, Inmaculada, de Diego-Damia, Alfredo, Irigaray, Rosa, Marín, Margarita, Balcells, Eva, Llunell, Antonia, Galdiz, Juan Bautista, Golpe, Rafael, Lacarcel, Celia, Cabrera, Carlos, Marin, Alicia, Soriano, Joan B., Lopez-Campos, Jose Luis, Soler-Cataluña, Juan José, and de-Torres, Juan P.

Published
2015
Full Text
View/download PDF

11. Clinical Application of the COPD Assessment Test: Longitudinal Data From the COPD History Assessment in Spain (CHAIN) Cohort

Author

de Torres, Juan P., Marin, Jose M., Martinez-Gonzalez, Cristina, de Lucas-Ramos, Pilar, Mir-Viladrich, Isabel, Cosio, Borja, Peces-Barba, German, Calle-Rubio, Miryam, Solanes-García, Ingrid, Balbin, Ramón Agüero, de Diego-Damia, Alfredo, Feu-Collado, Nuria, Michavila, Inmaculada Alfageme, Irigaray, Rosa, Balcells, Eva, Casanovas, Antònia Llunell, Galdiz Iturri, Juan Bautista, Royo, Margarita Marín, Soler-Cataluña, Juan J., Lopez-Campos, Jose Luis, Soriano, Joan B., and Casanova, Ciro

Published
2014
Full Text
View/download PDF

12. Biomarkers to predict FEV1 decline in smokers and early-onset COPD

Author

Gotera, Carolina, primary, Pereira Vega, Antonio, additional, García Barrera, Tamara, additional, Marín Trigo, José María, additional, Casanova Macario, Ciro, additional, García-Cosío Piqueras, Borja, additional, Mir Viladrich, Isabel, additional, Solanes García, Ingrid, additional, Gómez Ariza, José Luis, additional, López Campos, José Luis, additional, Seijo Maceiras, Luis, additional, Feu Collado, Nuria, additional, Cabrera López, Carlos, additional, Amado Diago, Carlos, additional, Romero Plaza, Amparo, additional, De Torres Tajes, Juan Pablo, additional, Padrón Fraysse, Luis Alejandero, additional, Márquez Martín, Eduardo, additional, Marín Royo, Margarita, additional, Balcells Vilarnau, Eva, additional, Llunell Casanovas, Antonia, additional, Martínez González, Cristina, additional, Galdiz Iturri, Juan Bautista, additional, Lacárcel Bautista, Celia, additional, García Garrido, Sandra, additional, and Peces-Barba, Germán, additional

Published
2020
Full Text
View/download PDF

13. Tuberculosis contacts study in Spain: preliminary results

Author

Gullon Blanco, Jose Antonio, primary, Álvarez Mavarez, Juan Diego, additional, Rodrigo Sanz, Teresa, additional, Villanueva Montes, Manuel Angel, additional, Alvarez Navascues, Fernando, additional, Rodríguez López, Juan, additional, Tabernero Huguet, Eva, additional, Lopez Aranaga, Isabel, additional, Sabria Mestres, Josefina, additional, Anibarro García, Luis, additional, Dominguez Castellano, Angel, additional, Penas Truque, Anton, additional, Mir Viladrich, Isabel, additional, Dorronsoro Quintana, Silvia, additional, Altube Urrengoetxea, Lander, additional, Medina Galardo, Juan Francisco, additional, Somoza González, María, additional, Otero Santiago, María, additional, and García Garcia, José María, additional

Published
2020
Full Text
View/download PDF

14. Metabolomics identifies biomarkers of exacerbations in smokers with and without COPD

Author

Gotera, Carolina, primary, Pereira Vega, Antonio, additional, García Barrera, Tamara, additional, Marín Trigo, José María, additional, Casanova Macario, Ciro, additional, García-Cosío, Borja, additional, Mir Viladrich, Isabel, additional, Solanes García, Ingrid, additional, Gómez Ariza, José Luis, additional, López Campos, José Luis, additional, Seijo Maceiras, Luis, additional, Feu Collado, Nuria, additional, Cabrera López, Carlos, additional, Amado Diago, Carlos, additional, Romero Plaza, Amparo, additional, De Torres Tajes, Juan Pablo, additional, Padrón Fraysse, Luis Alejandro, additional, Callejón Leblic, Belén, additional, Márquez Martín, Eduardo, additional, Marín Royo, Margarita, additional, Balcells Vilarnau, Eva, additional, Llunell Casanovas, Antonia, additional, Martínez González, Cristina, additional, Galdiz Iturri, Juan Bautista, additional, Lacárcel Bautista, Celia, additional, García Garrido, Sandra, additional, and Peces-Barba, Germán, additional

Published
2020
Full Text
View/download PDF

15. [Translated article] Tuberculosis contacts tracing in Spain: Cost analysis

Author

Navascues, Fernando Álvarez, Somoza-González, María, Anchorena, Christian, Domínguez-Castellano, Ángel, Penas-Truque, Antón, Dorronsoro-Quintana, Silvia, Medina-Gallardo, Juan-Francisco, Altube-Urrengoetxea, Lander, Otero-Santiago, María, Rodríguez-García, Concepción, Rodríguez-López, Juan, Gullón-Blanco, José Antonio, Rodrigo-Sanz, Teresa, Tabernero-Huguet, Eva, Sabría-Mestres, Josefina, Anibarro, Luis, Villanueva-Montes, Manuel-Ángel, Mir-Viladrich, Isabel, Álvarez-Mavarez, Juan-Diego, and García-García, José-María

Published
2022
Full Text
View/download PDF

16. Metabolomic analysis of severe COPD. Study of biomarkers in the CHAIN cohort

Author

Gotera, Carolina, primary, Pereira Vega, Antonio, additional, García Barrera, Tamara, additional, Marín Trigo, José María, additional, Casanova Macario, Ciro, additional, García-Cosío Piqueras, Borja, additional, Mir Viladrich, Isabel, additional, Solanes García, Ingrid, additional, Gómez Ariza, José Luis, additional, López Campos, José Luis, additional, Seijo Maceiras, Luis, additional, Feu Collado, Nuria, additional, Cabrera Lopez, Carlos, additional, Agüero Balbin, Ramón, additional, Romero Plaza, Amparo, additional, De Torres Tajes, Juan Pablo, additional, Padrón Fraysse, Luis Alejandro, additional, Callejón Leblic, Belen, additional, Márquez Martín, Eduardo, additional, Marín Royo, Margarita, additional, Balcells Vilarnau, Eva, additional, Llunel Casanova, Antonia, additional, Martínez González, Cristina, additional, Galdiz Iturri, Juan Bautista, additional, Lacárcel Bautista, Celia, additional, and Peces-Barba, Germán, additional

Published
2019
Full Text
View/download PDF

17. IGRA testing in patients with immune-mediated inflammatory diseases: which factors influence the results?

Author

González-Moreno, Juan, García-Gasalla, Mercedes, Losada-López, Inés, Cifuentes Luna, Carmen, Mir Viladrich, Isabel, Fernández-Baca, Victoria, Serrano, Araceli, Juan Mas, Antonio, Riera-Oliver, Joan, and Payeras Cifre, Antoni

Subjects
TUBERCULOSIS, AUTOIMMUNE diseases, IMMUNOSUPPRESSION, GLUCOCORTICOIDS, CHRONIC diseases
Abstract

Diagnosis of latent tuberculosis infection in patients with immune-mediated inflammatory chronic diseases (IMIDs) can be challenged as diagnostic test reliability could be impaired by immunosuppression. We retrospectively analyzed the Quantiferon Gold-Test in-Tube (QFT-G-IT) results of all patients with IMIDs seen at the Department of Internal Medicine of Son Llàtzer Hospital, Palma de Mallorca (Spain), looking for the factors related to QFT-G-IT indeterminate results. During the study period (2008-2015), 520 patients met the inclusion criteria. Factors associated with indeterminate QFT-G-IT results in a univariate analysis were inflammatory bowel disease, disease activity, lymphopenia, and medium-to-high doses of corticosteroids. In a subsequent multivariate analysis, only lymphopenia (defined as < 1500 cells) was associated with indeterminate QFT-G-IT results. Lymphocyte count was the only factor independently associated with an increased number of indeterminate QFT-G-IT results in patients with different autoimmune diseases. Others factors such as the use of medium-to-high doses of corticosteroids should be considered before testing with QFT-G-IT. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

18. Role of QuantiFERON®-TB Gold In-Tube in tuberculosis contact investigation: experience in a tuberculosis unit

Author

Gonzślez-Moreno, Juan, primary, García-Gasalla, Mercedes, additional, Gállego-Lezaun, Cristina, additional, Fernández-Baca, Victoria, additional, Mir Viladrich, Isabel, additional, Cifuentes-Luna, Carmen, additional, Serrano Bujalance, Araceli, additional, Salom Vallespir, Andrea, additional, and Payeras Cifre, Antoni, additional

Published
2015
Full Text
View/download PDF

19. New GOLD classification: longitudinal data on group assignment

Author

Universidad de Sevilla. Departamento de Medicina, Casanova, Ciro, Marin, Jose M, Martínez-González, Cristina, Lucas-Ramos, Pilar de, Mir-Viladrich, Isabel, Cosio, Borja, Alfageme Michavila, Inmaculada, López-Campos Bodineau, José Luis, Torres, Juan de, Universidad de Sevilla. Departamento de Medicina, Casanova, Ciro, Marin, Jose M, Martínez-González, Cristina, Lucas-Ramos, Pilar de, Mir-Viladrich, Isabel, Cosio, Borja, Alfageme Michavila, Inmaculada, López-Campos Bodineau, José Luis, and Torres, Juan de

Abstract

Rationale: Little is known about the longitudinal changes associated with using the 2013 update of the multidimensional GOLD strategy for chronic obstructive pulmonary disease (COPD). Objective: To determine the COPD patient distribution of the new GOLD proposal and evaluate how this classification changes over one year compared with the previous GOLD staging based on spirometry only. Methods: We analyzed data from the CHAIN study, a multicenter observational Spanish cohort of COPD patients who are monitored annually. Categories were defined according to the proposed GOLD: FEV1%, mMRC dyspnea, COPD Assessment Test (CAT), Clinical COPD Questionnaire (CCQ), and exacerbations-hospitalizations. One-year follow-up information was available for all variables except CCQ data. Results: At baseline, 828 stable COPD patients were evaluated. On the basis of mMRC dyspnea versus CAT, the patients were distributed as follows: 38.2% vs. 27.2% in group A, 17.6% vs. 28.3% in group B, 15.8% vs. 12.9% in group C, and 28.4% vs. 31.6% in group D. Information was available for 526 patients at one year: 64.2% of patients remained in the same group but groups C and D show different degrees of variability. The annual progression by group was mainly associated with one-year changes in CAT scores (RR, 1.138; 95%CI: 1.074-1.206) and BODE index values (RR, 2.012; 95%CI: 1.487-2.722). Conclusions: In the new GOLD grading classification, the type of tool used to determine the level of symptoms can substantially alter the group assignment. A change in category after one year was associated with longitudinal changes in the CAT and BODE index.

Published
2014

20. Valor de QuantiFERON-TB Gold Test in Tube en el diagnóstico de tuberculosis pulmonar y extrapulmonar

Author

Garcia-Gasalla, Mercedes, primary, Fernández-Baca, Victoria, additional, Mir-Viladrich, Isabel, additional, Cifuentes-Luna, Carmen, additional, Campins-Roselló, Antoni, additional, Payeras-Cifre, Antoni, additional, Serrano-Bujalance, Araceli, additional, Ortiz-Monjo, Alicia, additional, Pons-Vives, Salvador, additional, and Gallegos-Alvarez, Carmen, additional

Published
2010
Full Text
View/download PDF

22. New GOLD classification: longitudinal data on group assignment.

Author

Casanova, Ciro, Marin, Jose M., Martinez-Gonzalez, Cristina, de Lucas-Ramos, Pilar, Mir-Viladrich, Isabel, Cosio, Borja, Peces-Barba, German, Calle-Rubio, Miryam, Solanes-García, Ingrid, Agüero, Ramón, de Diego-Damia, Alfredo, Feu-Collado, Nuria, Alfageme, Inmaculada, Irigaray, Rosa, Balcells, Eva, Llunell, Antonia, Galdiz, Juan Bautista, Marín, Margarita, Soler-Cataluña, Juan José, and Lopez-Campos, Jose Luis

Subjects
OBSTRUCTIVE lung diseases, SPIROMETRY, DISEASE progression, LONGITUDINAL method, DYSPNEA
Abstract

Rationale: Little is known about the longitudinal changes associated with using the 2013 update of the multidimensional GOLD strategy for chronic obstructive pulmonary disease (COPD). Objective: To determine the COPD patient distribution of the new GOLD proposal and evaluate how this classification changes over one year compared with the previous GOLD staging based on spirometry only. Methods: We analyzed data from the CHAIN study, a multicenter observational Spanish cohort of COPD patients who are monitored annually. Categories were defined according to the proposed GOLD: FEV1%, mMRC dyspnea, COPD Assessment Test (CAT), Clinical COPD Questionnaire (CCQ), and exacerbations-hospitalizations. One-year follow-up information was available for all variables except CCQ data. Results: At baseline, 828 stable COPD patients were evaluated. On the basis of mMRC dyspnea versus CAT, the patients were distributed as follows: 38.2% vs. 27.2% in group A, 17.6% vs. 28.3% in group B, 15.8% vs. 12.9% in group C, and 28.4% vs. 31.6% in group D. Information was available for 526 patients at one year: 64.2% of patients remained in the same group but groups C and D show different degrees of variability. The annual progression by group was mainly associated with one-year changes in CAT scores (RR, 1.138; 95%CI: 1.074-1.206) and BODE index values (RR, 2.012; 95%CI: 1.487-2.722). Conclusions: In the new GOLD grading classification, the type of tool used to determine the level of symptoms can substantially alter the group assignment. A change in category after one year was associated with longitudinal changes in the CAT and BODE index. [ABSTRACT FROM AUTHOR]

Published
2014
Full Text
View/download PDF

23. WITHDRAWN: Tuberculosis contacts tracing in Spain: Cost analysis

Author

Navascues, Fernando Álvarez, Somoza-González, María, Anchorena, Christian, Domínguez-Castellano, Ángel, Penas-Truque, Antón, Dorronsoro-Quintana, Silvia, Medina-Gallardo, Juan-Francisco, Altube-Urrengoetxea, Lander, Otero-Santiago, María, Rodríguez-García, Concepción, Rodríguez-López, Juan, Gullón-Blanco, José Antonio, Rodrigo-Sanz, Teresa, Tabernero-Huguet, Eva, Sabría-Mestres, Josefina, Anibarro, Luis, Villanueva-Montes, Manuel-Ángel, Mir-Viladrich, Isabel, Álvarez-Mavarez, Juan-Diego, and García-García, José-María

Full Text
View/download PDF

25. Tuberculosis Contacts Tracing in Spain: Cost Analysis.

Author

Gullón-Blanco JA, Rodrigo-Sanz T, Tabernero-Huguet E, Sabría-Mestres J, Anibarro L, Villanueva-Montes MÁ, Mir-Viladrich I, Álvarez-Mavarez JD, and García-García JM

Subjects
Contact Tracing, Costs and Cost Analysis, Humans, Spain epidemiology, Tuberculin Test, Tuberculosis epidemiology, Tuberculosis prevention & control
Published
2022
Full Text
View/download PDF

27. [Quantiferon-TB Gold In-Tube test in the diagnosis of pulmonary and extra-pulmonary tuberculosis].

Author

Garcia-Gasalla M, Fernández-Baca V, Mir-Viladrich I, Cifuentes-Luna C, Campins-Roselló A, Payeras-Cifre A, Serrano-Bujalance A, Ortiz-Monjo A, Pons-Vives S, and Gallegos-Alvarez C

Subjects
Adolescent, Adult, Aged, Comorbidity, Emigrants and Immigrants, Female, HIV Infections complications, HIV Infections immunology, Humans, Interferon-gamma metabolism, Male, Middle Aged, Prospective Studies, Reproducibility of Results, Sensitivity and Specificity, Tuberculin Test, Tuberculosis complications, Tuberculosis immunology, Tuberculosis, Pulmonary diagnosis, Tuberculosis, Pulmonary immunology, Young Adult, Antigens, Bacterial, Reagent Kits, Diagnostic, T-Lymphocytes metabolism, Tuberculosis diagnosis
Abstract

Introduction: The Interferon-γ in vitro detection tests could be a useful tool in the diagnosis of active tuberculosis compared to Mycobacterium tuberculosis (MTB)., Methods: The QuantiFERON-TB-Gold in Tube (QFG-IT) test was performed on the blood of 118 patients with active tuberculosis and the results compared with the tuberculin test., Results: The QFG-IT test was positive in 94 cases (79.7%), negative in 17 (14.4%) and indeterminate in 7 (5.9%). A negative or indeterminate QFG-IT test was more common in older patients (P=0.017) and in cases with negative smear tests (P=0.041). The kappa agreement between the tuberculin and QFG-IT tests was 74.5% with a kappa value of 0.45 (SE:0.136). Thirteen of the patients studied were infected with HIV and the tuberculin was positive in 5 of the 12 cases (38.5%) in whom it was performed, with the QFG-IT being positive in 9/13 (69.2%)., Conclusions: The QFG-IT test may be a useful complimentary tool to the tuberculin test in the diagnosis of tuberculosis., (Copyright © 2009 Elsevier España, S.L. All rights reserved.)

Published
2010
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results